Parameter
| Biomarker | EPHA2 | Full name | EPH receptor A2 | Molecular Type | membranin |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Targeted therapy targets, prognostic evaluation | ||
| Disease | Osteosarcoma (OS) | Disease Subtypes | / | ||
| Organ | Bone | Test Sample / Technology Platform | Tumor tissue、CTCs (FACS、IHC) | ||
| Pathobiological Mechanisms | Mediates PI3K/Akt and MEK/ERK signaling pathways to promote angiogenesis and metastasis | ||||
| Clinical Availability Status | Preclinical studies are mature | ||||
| Notes and Dynamics | CAR-T targeted therapy has demonstrated efficacy in animal models, capable of eliminating metastatic lesions. | ||||